CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
22 hedge funds and large institutions have $1.93M invested in Carisma Therapeutics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$382K | |
| 2 | +$61K | |
| 3 | +$36K | |
| 4 |
Citigroup
New York
|
+$167 |
Top Sellers
| 1 | -$148K | |
| 2 | -$77K | |
| 3 | -$35K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$22K |